Controls based on viral nucleic acids extracted from either an infected patient or from live virus propagated in cell culture have safety and security concerns.
The global Synthetic Viral Controls market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Synthetic Viral Controls is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Synthetic Viral Controls is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Synthetic Viral Controls in Child is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Synthetic Viral Controls include Twist Bioscience, Vector Biolabs, Premade Lentivirus Particles, Telesis Bio, Thermo Fisher Scientific, Sigma Aldrich, Antibody Engineering, Amyris and Precigen, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Synthetic Viral Controls, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Synthetic Viral Controls.
The Synthetic Viral Controls market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Synthetic Viral Controls market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Synthetic Viral Controls companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Twist Bioscience
Vector Biolabs
Premade Lentivirus Particles
Telesis Bio
Thermo Fisher Scientific
Sigma Aldrich
Antibody Engineering
Amyris
Precigen
Ginkgo Bioworks
Codexis
Impossible Foods
National Resilience
ElevateBio
Insitro
Apeel Sciences
Segment by Type
Monkeypox Controls
SARS-COV-2 CONTROLS
Respiratory Virus Controls
Segment by Application
Child
Teenager
Youth
Middle-Aged
Elder
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Synthetic Viral Controls companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Synthetic Viral Controls Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monkeypox Controls
1.2.3 SARS-COV-2 CONTROLS
1.2.4 Respiratory Virus Controls
1.3 Market by Application
1.3.1 Global Synthetic Viral Controls Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Child
1.3.3 Teenager
1.3.4 Youth
1.3.5 Middle-Aged
1.3.6 Elder
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Synthetic Viral Controls Market Perspective (2018-2029)
2.2 Synthetic Viral Controls Growth Trends by Region
2.2.1 Global Synthetic Viral Controls Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Synthetic Viral Controls Historic Market Size by Region (2018-2023)
2.2.3 Synthetic Viral Controls Forecasted Market Size by Region (2024-2029)
2.3 Synthetic Viral Controls Market Dynamics
2.3.1 Synthetic Viral Controls Industry Trends
2.3.2 Synthetic Viral Controls Market Drivers
2.3.3 Synthetic Viral Controls Market Challenges
2.3.4 Synthetic Viral Controls Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Synthetic Viral Controls Players by Revenue
3.1.1 Global Top Synthetic Viral Controls Players by Revenue (2018-2023)
3.1.2 Global Synthetic Viral Controls Revenue Market Share by Players (2018-2023)
3.2 Global Synthetic Viral Controls Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Synthetic Viral Controls Revenue
3.4 Global Synthetic Viral Controls Market Concentration Ratio
3.4.1 Global Synthetic Viral Controls Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Synthetic Viral Controls Revenue in 2022
3.5 Synthetic Viral Controls Key Players Head office and Area Served
3.6 Key Players Synthetic Viral Controls Product Solution and Service
3.7 Date of Enter into Synthetic Viral Controls Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Synthetic Viral Controls Breakdown Data by Type
4.1 Global Synthetic Viral Controls Historic Market Size by Type (2018-2023)
4.2 Global Synthetic Viral Controls Forecasted Market Size by Type (2024-2029)
5 Synthetic Viral Controls Breakdown Data by Application
5.1 Global Synthetic Viral Controls Historic Market Size by Application (2018-2023)
5.2 Global Synthetic Viral Controls Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Synthetic Viral Controls Market Size (2018-2029)
6.2 North America Synthetic Viral Controls Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Synthetic Viral Controls Market Size by Country (2018-2023)
6.4 North America Synthetic Viral Controls Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Synthetic Viral Controls Market Size (2018-2029)
7.2 Europe Synthetic Viral Controls Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Synthetic Viral Controls Market Size by Country (2018-2023)
7.4 Europe Synthetic Viral Controls Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Synthetic Viral Controls Market Size (2018-2029)
8.2 Asia-Pacific Synthetic Viral Controls Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Synthetic Viral Controls Market Size by Region (2018-2023)
8.4 Asia-Pacific Synthetic Viral Controls Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Synthetic Viral Controls Market Size (2018-2029)
9.2 Latin America Synthetic Viral Controls Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Synthetic Viral Controls Market Size by Country (2018-2023)
9.4 Latin America Synthetic Viral Controls Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Synthetic Viral Controls Market Size (2018-2029)
10.2 Middle East & Africa Synthetic Viral Controls Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Synthetic Viral Controls Market Size by Country (2018-2023)
10.4 Middle East & Africa Synthetic Viral Controls Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Twist Bioscience
11.1.1 Twist Bioscience Company Detail
11.1.2 Twist Bioscience Business Overview
11.1.3 Twist Bioscience Synthetic Viral Controls Introduction
11.1.4 Twist Bioscience Revenue in Synthetic Viral Controls Business (2018-2023)
11.1.5 Twist Bioscience Recent Development
11.2 Vector Biolabs
11.2.1 Vector Biolabs Company Detail
11.2.2 Vector Biolabs Business Overview
11.2.3 Vector Biolabs Synthetic Viral Controls Introduction
11.2.4 Vector Biolabs Revenue in Synthetic Viral Controls Business (2018-2023)
11.2.5 Vector Biolabs Recent Development
11.3 Premade Lentivirus Particles
11.3.1 Premade Lentivirus Particles Company Detail
11.3.2 Premade Lentivirus Particles Business Overview
11.3.3 Premade Lentivirus Particles Synthetic Viral Controls Introduction
11.3.4 Premade Lentivirus Particles Revenue in Synthetic Viral Controls Business (2018-2023)
11.3.5 Premade Lentivirus Particles Recent Development
11.4 Telesis Bio
11.4.1 Telesis Bio Company Detail
11.4.2 Telesis Bio Business Overview
11.4.3 Telesis Bio Synthetic Viral Controls Introduction
11.4.4 Telesis Bio Revenue in Synthetic Viral Controls Business (2018-2023)
11.4.5 Telesis Bio Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Synthetic Viral Controls Introduction
11.5.4 Thermo Fisher Scientific Revenue in Synthetic Viral Controls Business (2018-2023)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Sigma Aldrich
11.6.1 Sigma Aldrich Company Detail
11.6.2 Sigma Aldrich Business Overview
11.6.3 Sigma Aldrich Synthetic Viral Controls Introduction
11.6.4 Sigma Aldrich Revenue in Synthetic Viral Controls Business (2018-2023)
11.6.5 Sigma Aldrich Recent Development
11.7 Antibody Engineering
11.7.1 Antibody Engineering Company Detail
11.7.2 Antibody Engineering Business Overview
11.7.3 Antibody Engineering Synthetic Viral Controls Introduction
11.7.4 Antibody Engineering Revenue in Synthetic Viral Controls Business (2018-2023)
11.7.5 Antibody Engineering Recent Development
11.8 Amyris
11.8.1 Amyris Company Detail
11.8.2 Amyris Business Overview
11.8.3 Amyris Synthetic Viral Controls Introduction
11.8.4 Amyris Revenue in Synthetic Viral Controls Business (2018-2023)
11.8.5 Amyris Recent Development
11.9 Precigen
11.9.1 Precigen Company Detail
11.9.2 Precigen Business Overview
11.9.3 Precigen Synthetic Viral Controls Introduction
11.9.4 Precigen Revenue in Synthetic Viral Controls Business (2018-2023)
11.9.5 Precigen Recent Development
11.10 Ginkgo Bioworks
11.10.1 Ginkgo Bioworks Company Detail
11.10.2 Ginkgo Bioworks Business Overview
11.10.3 Ginkgo Bioworks Synthetic Viral Controls Introduction
11.10.4 Ginkgo Bioworks Revenue in Synthetic Viral Controls Business (2018-2023)
11.10.5 Ginkgo Bioworks Recent Development
11.11 Codexis
11.11.1 Codexis Company Detail
11.11.2 Codexis Business Overview
11.11.3 Codexis Synthetic Viral Controls Introduction
11.11.4 Codexis Revenue in Synthetic Viral Controls Business (2018-2023)
11.11.5 Codexis Recent Development
11.12 Impossible Foods
11.12.1 Impossible Foods Company Detail
11.12.2 Impossible Foods Business Overview
11.12.3 Impossible Foods Synthetic Viral Controls Introduction
11.12.4 Impossible Foods Revenue in Synthetic Viral Controls Business (2018-2023)
11.12.5 Impossible Foods Recent Development
11.13 National Resilience
11.13.1 National Resilience Company Detail
11.13.2 National Resilience Business Overview
11.13.3 National Resilience Synthetic Viral Controls Introduction
11.13.4 National Resilience Revenue in Synthetic Viral Controls Business (2018-2023)
11.13.5 National Resilience Recent Development
11.14 ElevateBio
11.14.1 ElevateBio Company Detail
11.14.2 ElevateBio Business Overview
11.14.3 ElevateBio Synthetic Viral Controls Introduction
11.14.4 ElevateBio Revenue in Synthetic Viral Controls Business (2018-2023)
11.14.5 ElevateBio Recent Development
11.15 Insitro
11.15.1 Insitro Company Detail
11.15.2 Insitro Business Overview
11.15.3 Insitro Synthetic Viral Controls Introduction
11.15.4 Insitro Revenue in Synthetic Viral Controls Business (2018-2023)
11.15.5 Insitro Recent Development
11.16 Apeel Sciences
11.16.1 Apeel Sciences Company Detail
11.16.2 Apeel Sciences Business Overview
11.16.3 Apeel Sciences Synthetic Viral Controls Introduction
11.16.4 Apeel Sciences Revenue in Synthetic Viral Controls Business (2018-2023)
11.16.5 Apeel Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Twist Bioscience
Vector Biolabs
Premade Lentivirus Particles
Telesis Bio
Thermo Fisher Scientific
Sigma Aldrich
Antibody Engineering
Amyris
Precigen
Ginkgo Bioworks
Codexis
Impossible Foods
National Resilience
ElevateBio
Insitro
Apeel Sciences
听
听
*If Applicable.
